

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | daunorubicin metabolic process (GO:0044597) | 6.05168941 |
| 2 | polyketide metabolic process (GO:0030638) | 6.05168941 |
| 3 | doxorubicin metabolic process (GO:0044598) | 6.05168941 |
| 4 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 5.87545370 |
| 5 | negative regulation of dendrite morphogenesis (GO:0050774) | 5.53292923 |
| 6 | peripheral nervous system neuron development (GO:0048935) | 5.49750371 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.13292978 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.13292978 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.13292978 |
| 10 | behavioral response to nicotine (GO:0035095) | 5.07806892 |
| 11 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.99254770 |
| 12 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 4.95283855 |
| 13 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 4.95283855 |
| 14 | kynurenine metabolic process (GO:0070189) | 4.71367495 |
| 15 | indolalkylamine metabolic process (GO:0006586) | 4.62846203 |
| 16 | tryptophan metabolic process (GO:0006568) | 4.37006482 |
| 17 | G-protein coupled receptor internalization (GO:0002031) | 4.33809096 |
| 18 | cellular response to ATP (GO:0071318) | 4.32637007 |
| 19 | detection of temperature stimulus (GO:0016048) | 4.32334133 |
| 20 | adenosine metabolic process (GO:0046085) | 4.30478641 |
| 21 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 4.15759585 |
| 22 | urinary tract smooth muscle contraction (GO:0014848) | 4.06673772 |
| 23 | negative regulation of heart rate (GO:0010459) | 3.96400992 |
| 24 | sulfation (GO:0051923) | 3.92428125 |
| 25 | regulation of platelet aggregation (GO:0090330) | 3.87638095 |
| 26 | fucose catabolic process (GO:0019317) | 3.77695964 |
| 27 | L-fucose metabolic process (GO:0042354) | 3.77695964 |
| 28 | L-fucose catabolic process (GO:0042355) | 3.77695964 |
| 29 | cellular biogenic amine catabolic process (GO:0042402) | 3.74174957 |
| 30 | amine catabolic process (GO:0009310) | 3.74174957 |
| 31 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.65447401 |
| 32 | indole-containing compound metabolic process (GO:0042430) | 3.60167525 |
| 33 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.51431290 |
| 34 | neuronal action potential (GO:0019228) | 3.49580544 |
| 35 | response to pheromone (GO:0019236) | 3.48062989 |
| 36 | energy homeostasis (GO:0097009) | 3.47580540 |
| 37 | detection of light stimulus involved in visual perception (GO:0050908) | 3.42514054 |
| 38 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.42514054 |
| 39 | reflex (GO:0060004) | 3.38474210 |
| 40 | response to pain (GO:0048265) | 3.36075117 |
| 41 | positive regulation of macrophage differentiation (GO:0045651) | 3.32692485 |
| 42 | histamine secretion (GO:0001821) | 3.31846504 |
| 43 | gamma-aminobutyric acid transport (GO:0015812) | 3.30818033 |
| 44 | cellular ketone body metabolic process (GO:0046950) | 3.26955125 |
| 45 | negative regulation of dendrite development (GO:2000171) | 3.24092784 |
| 46 | behavioral response to pain (GO:0048266) | 3.22711101 |
| 47 | axoneme assembly (GO:0035082) | 3.17176356 |
| 48 | NAD biosynthetic process (GO:0009435) | 3.15589385 |
| 49 | neuron fate specification (GO:0048665) | 3.14103354 |
| 50 | regulation of cell communication by electrical coupling (GO:0010649) | 3.12887798 |
| 51 | superoxide anion generation (GO:0042554) | 3.11630502 |
| 52 | cAMP catabolic process (GO:0006198) | 3.11109250 |
| 53 | regulation of relaxation of muscle (GO:1901077) | 3.09782066 |
| 54 | primary amino compound metabolic process (GO:1901160) | 3.09016173 |
| 55 | platelet dense granule organization (GO:0060155) | 3.06170566 |
| 56 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.05844581 |
| 57 | DNA deamination (GO:0045006) | 3.01263678 |
| 58 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.98375461 |
| 59 | serotonin metabolic process (GO:0042428) | 2.97462713 |
| 60 | monocyte chemotaxis (GO:0002548) | 2.96796180 |
| 61 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.95525151 |
| 62 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.95239277 |
| 63 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.93063846 |
| 64 | ketone body metabolic process (GO:1902224) | 2.92313855 |
| 65 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.91990173 |
| 66 | detection of calcium ion (GO:0005513) | 2.89492511 |
| 67 | presynaptic membrane assembly (GO:0097105) | 2.88768079 |
| 68 | cyclic nucleotide catabolic process (GO:0009214) | 2.87592271 |
| 69 | negative regulation of telomere maintenance (GO:0032205) | 2.86823596 |
| 70 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.86349887 |
| 71 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.86349887 |
| 72 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.86349887 |
| 73 | detection of molecule of bacterial origin (GO:0032490) | 2.85315965 |
| 74 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.85071435 |
| 75 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.84565225 |
| 76 | positive regulation of muscle hypertrophy (GO:0014742) | 2.84565225 |
| 77 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.82431279 |
| 78 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.81973044 |
| 79 | positive regulation of action potential (GO:0045760) | 2.80260343 |
| 80 | aromatic amino acid family catabolic process (GO:0009074) | 2.78763188 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 2.78471595 |
| 82 | metanephric mesenchyme development (GO:0072075) | 2.77776581 |
| 83 | behavioral response to ethanol (GO:0048149) | 2.77568015 |
| 84 | photoreceptor cell maintenance (GO:0045494) | 2.77497855 |
| 85 | piRNA metabolic process (GO:0034587) | 2.76850081 |
| 86 | multicellular organism reproduction (GO:0032504) | 2.76136121 |
| 87 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.74730670 |
| 88 | auditory receptor cell stereocilium organization (GO:0060088) | 2.74547115 |
| 89 | transmission of nerve impulse (GO:0019226) | 2.73597433 |
| 90 | negative regulation of bone resorption (GO:0045779) | 2.72576461 |
| 91 | histamine transport (GO:0051608) | 2.72276341 |
| 92 | regulation of pigment cell differentiation (GO:0050932) | 2.71649796 |
| 93 | negative regulation of smooth muscle contraction (GO:0045986) | 2.71498587 |
| 94 | opioid receptor signaling pathway (GO:0038003) | 2.70678862 |
| 95 | positive regulation of defense response to virus by host (GO:0002230) | 2.70329978 |
| 96 | sympathetic nervous system development (GO:0048485) | 2.70134343 |
| 97 | protein import into peroxisome matrix (GO:0016558) | 2.68677506 |
| 98 | positive regulation of steroid hormone secretion (GO:2000833) | 2.66578145 |
| 99 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.65417171 |
| 100 | negative regulation of stem cell proliferation (GO:2000647) | 2.64704163 |
| 101 | dopamine transport (GO:0015872) | 2.64355873 |
| 102 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.64139775 |
| 103 | serotonin receptor signaling pathway (GO:0007210) | 2.63872038 |
| 104 | extracellular negative regulation of signal transduction (GO:1900116) | 2.63708277 |
| 105 | extracellular regulation of signal transduction (GO:1900115) | 2.63708277 |
| 106 | tachykinin receptor signaling pathway (GO:0007217) | 2.62629818 |
| 107 | epithelial cilium movement (GO:0003351) | 2.61860860 |
| 108 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.61798951 |
| 109 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.61390500 |
| 110 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.60409230 |
| 111 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.60026505 |
| 112 | inner ear receptor stereocilium organization (GO:0060122) | 2.59368910 |
| 113 | cell proliferation in forebrain (GO:0021846) | 2.59298850 |
| 114 | cranial nerve development (GO:0021545) | 2.58971381 |
| 115 | regulation of sarcomere organization (GO:0060297) | 2.57264635 |
| 116 | negative regulation of platelet activation (GO:0010544) | 2.57068422 |
| 117 | response to ATP (GO:0033198) | 2.56377802 |
| 118 | nonmotile primary cilium assembly (GO:0035058) | 2.56027659 |
| 119 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.53744732 |
| 120 | regulation of action potential (GO:0098900) | 2.53245824 |
| 121 | rRNA catabolic process (GO:0016075) | 2.52066304 |
| 122 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.51227901 |
| 123 | peristalsis (GO:0030432) | 2.51203429 |
| 124 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.50970556 |
| 125 | negative regulation of protein oligomerization (GO:0032460) | 2.49814768 |
| 126 | negative regulation of mast cell activation (GO:0033004) | 2.49717136 |
| 127 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.49691610 |
| 128 | cellular response to exogenous dsRNA (GO:0071360) | 2.49566884 |
| 129 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.49271130 |
| 130 | positive regulation of mitochondrial fission (GO:0090141) | 2.49148575 |
| 131 | rhodopsin mediated signaling pathway (GO:0016056) | 2.48803648 |
| 132 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.48626053 |
| 133 | adaptation of signaling pathway (GO:0023058) | 2.48509140 |
| 134 | presynaptic membrane organization (GO:0097090) | 2.47362344 |
| 135 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 2.47164185 |
| 136 | regulation of activation of Janus kinase activity (GO:0010533) | 2.44416889 |
| 137 | prostate gland growth (GO:0060736) | 2.43479915 |
| 138 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.43208838 |
| 139 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.43208838 |
| 140 | NADH dehydrogenase complex assembly (GO:0010257) | 2.43208838 |
| 141 | positive regulation of fatty acid transport (GO:2000193) | 2.42966521 |
| 142 | kidney mesenchyme development (GO:0072074) | 2.42746079 |
| 143 | cellular response to nicotine (GO:0071316) | 2.42039881 |
| 144 | regulation of fever generation (GO:0031620) | 2.41965619 |
| 145 | sperm motility (GO:0030317) | 2.41591972 |
| 146 | signal peptide processing (GO:0006465) | 2.41326353 |
| 147 | protein polyglutamylation (GO:0018095) | 2.41271515 |
| 148 | regulation of memory T cell differentiation (GO:0043380) | 2.40820518 |
| 149 | regulation of cilium movement (GO:0003352) | 2.40483340 |
| 150 | regulation of neurotransmitter uptake (GO:0051580) | 2.39330655 |
| 151 | appendage development (GO:0048736) | 2.38615001 |
| 152 | limb development (GO:0060173) | 2.38615001 |
| 153 | retinal cone cell development (GO:0046549) | 2.38324481 |
| 154 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.37953340 |
| 155 | aromatic amino acid family metabolic process (GO:0009072) | 2.37365396 |
| 156 | regulation of muscle hypertrophy (GO:0014743) | 2.36825146 |
| 157 | positive regulation of mast cell activation (GO:0033005) | 2.36192078 |
| 158 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.35877963 |
| 159 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.35877963 |
| 160 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.35452216 |
| 161 | proline transport (GO:0015824) | 2.34004850 |
| 162 | positive regulation of interleukin-1 production (GO:0032732) | 2.33303615 |
| 163 | spinal cord motor neuron differentiation (GO:0021522) | 2.32963495 |
| 164 | action potential (GO:0001508) | 2.32424099 |
| 165 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.32221597 |
| 166 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.32147583 |
| 167 | regulation of gene silencing by miRNA (GO:0060964) | 2.32147583 |
| 168 | regulation of gene silencing by RNA (GO:0060966) | 2.32147583 |
| 169 | positive regulation of vascular permeability (GO:0043117) | 2.31578248 |
| 170 | protein localization to cilium (GO:0061512) | 2.31472544 |
| 171 | regulation of hippo signaling (GO:0035330) | 2.31446278 |
| 172 | cilium movement (GO:0003341) | 2.31088861 |
| 173 | retinal ganglion cell axon guidance (GO:0031290) | 2.30566624 |
| 174 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.30331561 |
| 175 | photoreceptor cell development (GO:0042461) | 2.27744446 |
| 176 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.27599158 |
| 177 | thyroid hormone metabolic process (GO:0042403) | 2.27551694 |
| 178 | cellular response to gamma radiation (GO:0071480) | 2.27066623 |
| 179 | mechanoreceptor differentiation (GO:0042490) | 2.26175967 |
| 180 | negative regulation of myoblast differentiation (GO:0045662) | 2.26090157 |
| 181 | membrane depolarization during action potential (GO:0086010) | 2.24479691 |
| 182 | positive regulation of heat generation (GO:0031652) | 2.24339417 |
| 183 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.24152688 |
| 184 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.21407615 |
| 185 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.21264155 |
| 186 | DNA integration (GO:0015074) | 2.21160094 |
| 187 | intraciliary transport (GO:0042073) | 2.21136780 |
| 188 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.20373893 |
| 189 | cellular response to alkaloid (GO:0071312) | 2.18557793 |
| 190 | regulation of glucokinase activity (GO:0033131) | 2.17822947 |
| 191 | regulation of hexokinase activity (GO:1903299) | 2.17822947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.01604378 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.29922346 |
| 3 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.78359569 |
| 4 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.71349076 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.66433431 |
| 6 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.49917496 |
| 7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.43609094 |
| 8 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.25121186 |
| 9 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.16390652 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.06977159 |
| 11 | P300_19829295_ChIP-Seq_ESCs_Human | 2.06016696 |
| 12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.99173312 |
| 13 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.97628760 |
| 14 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.96310168 |
| 15 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.96172957 |
| 16 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.96167607 |
| 17 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.92361698 |
| 18 | VDR_22108803_ChIP-Seq_LS180_Human | 1.86918698 |
| 19 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.84721213 |
| 20 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.81720160 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.81224492 |
| 22 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.81158409 |
| 23 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.81085675 |
| 24 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.80207183 |
| 25 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.78784976 |
| 26 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.78314233 |
| 27 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.77332913 |
| 28 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.72581275 |
| 29 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.72381831 |
| 30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.70758972 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.69991784 |
| 32 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.68056570 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.66028043 |
| 34 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.64535009 |
| 35 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.64440984 |
| 36 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.61646125 |
| 37 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.61425478 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.60689048 |
| 39 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.60388931 |
| 40 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.59877585 |
| 41 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.59359181 |
| 42 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.59307585 |
| 43 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.57319549 |
| 44 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.56349865 |
| 45 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.56349865 |
| 46 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.55092637 |
| 47 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.54396275 |
| 48 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.54354479 |
| 49 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.53378186 |
| 50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.52672743 |
| 51 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.52210644 |
| 52 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.51737825 |
| 53 | STAT3_23295773_ChIP-Seq_U87_Human | 1.51560595 |
| 54 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.49552634 |
| 55 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.47143192 |
| 56 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.47143192 |
| 57 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45059660 |
| 58 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.44484720 |
| 59 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.43487595 |
| 60 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.42750828 |
| 61 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.42679179 |
| 62 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.42448406 |
| 63 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.41744926 |
| 64 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.40315898 |
| 65 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.40238007 |
| 66 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39449046 |
| 67 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.39132866 |
| 68 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.36970704 |
| 69 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.36671944 |
| 70 | TCF4_23295773_ChIP-Seq_U87_Human | 1.35338481 |
| 71 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.34939776 |
| 72 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.34661803 |
| 73 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.34329892 |
| 74 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30782865 |
| 75 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.30737787 |
| 76 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.30737787 |
| 77 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.30506361 |
| 78 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.30401434 |
| 79 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.28836702 |
| 80 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28058984 |
| 81 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27150697 |
| 82 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.26961745 |
| 83 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26916815 |
| 84 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.26326458 |
| 85 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.26106575 |
| 86 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.24139040 |
| 87 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.23199894 |
| 88 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.22596507 |
| 89 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.22063602 |
| 90 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.21281109 |
| 91 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.20830110 |
| 92 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.20830110 |
| 93 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.20594885 |
| 94 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.20430925 |
| 95 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.19470259 |
| 96 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19058132 |
| 97 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18946797 |
| 98 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.18936880 |
| 99 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.18825974 |
| 100 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.18825974 |
| 101 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.18566241 |
| 102 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.18332537 |
| 103 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.17942695 |
| 104 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.16711525 |
| 105 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.16243388 |
| 106 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.16176950 |
| 107 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.16134581 |
| 108 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.15191629 |
| 109 | * JUN_21703547_ChIP-Seq_K562_Human | 1.14524989 |
| 110 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.14114750 |
| 111 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14007472 |
| 112 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13404661 |
| 113 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12991797 |
| 114 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.12296419 |
| 115 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.11962464 |
| 116 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.11855491 |
| 117 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11789189 |
| 118 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.11711062 |
| 119 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.11336063 |
| 120 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.11231877 |
| 121 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.10728940 |
| 122 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10400120 |
| 123 | EWS_26573619_Chip-Seq_HEK293_Human | 1.09869311 |
| 124 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.09492948 |
| 125 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.09064216 |
| 126 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.09028609 |
| 127 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08421678 |
| 128 | FUS_26573619_Chip-Seq_HEK293_Human | 1.07757665 |
| 129 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.07491879 |
| 130 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06735242 |
| 131 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.06450000 |
| 132 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.05643154 |
| 133 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.04518953 |
| 134 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04293916 |
| 135 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.03580162 |
| 136 | AR_20517297_ChIP-Seq_VCAP_Human | 1.02834921 |
| 137 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.02222335 |
| 138 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.01362923 |
| 139 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.99557403 |
| 140 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.99315811 |
| 141 | NCOR_22424771_ChIP-Seq_293T_Human | 0.99131029 |
| 142 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98358534 |
| 143 | TP53_16413492_ChIP-PET_HCT116_Human | 0.97222324 |
| 144 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.96664181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001986_abnormal_taste_sensitivity | 6.07479487 |
| 2 | MP0002735_abnormal_chemical_nociception | 5.91851967 |
| 3 | MP0001968_abnormal_touch/_nociception | 4.18666076 |
| 4 | MP0006276_abnormal_autonomic_nervous | 3.71144394 |
| 5 | MP0002736_abnormal_nociception_after | 3.67727514 |
| 6 | MP0003195_calcinosis | 3.45588275 |
| 7 | MP0001188_hyperpigmentation | 3.39920094 |
| 8 | MP0009697_abnormal_copulation | 2.96180128 |
| 9 | MP0010386_abnormal_urinary_bladder | 2.81395001 |
| 10 | MP0005171_absent_coat_pigmentation | 2.76690353 |
| 11 | MP0000372_irregular_coat_pigmentation | 2.74141509 |
| 12 | MP0003136_yellow_coat_color | 2.65795906 |
| 13 | MP0003646_muscle_fatigue | 2.61502461 |
| 14 | MP0005551_abnormal_eye_electrophysiolog | 2.53054474 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.47624188 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.26117220 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.21685449 |
| 18 | MP0001970_abnormal_pain_threshold | 2.17035823 |
| 19 | MP0005167_abnormal_blood-brain_barrier | 2.11494819 |
| 20 | MP0008872_abnormal_physiological_respon | 2.09265360 |
| 21 | MP0002733_abnormal_thermal_nociception | 2.08548821 |
| 22 | MP0005646_abnormal_pituitary_gland | 2.07748401 |
| 23 | MP0003880_abnormal_central_pattern | 2.04136825 |
| 24 | MP0008004_abnormal_stomach_pH | 2.02292822 |
| 25 | MP0002837_dystrophic_cardiac_calcinosis | 1.91211313 |
| 26 | MP0002277_abnormal_respiratory_mucosa | 1.78700726 |
| 27 | MP0008877_abnormal_DNA_methylation | 1.78301999 |
| 28 | MP0006292_abnormal_olfactory_placode | 1.73945531 |
| 29 | MP0002163_abnormal_gland_morphology | 1.72878926 |
| 30 | MP0005645_abnormal_hypothalamus_physiol | 1.72298487 |
| 31 | MP0004270_analgesia | 1.71805279 |
| 32 | MP0003011_delayed_dark_adaptation | 1.70062428 |
| 33 | MP0001485_abnormal_pinna_reflex | 1.68191265 |
| 34 | MP0000015_abnormal_ear_pigmentation | 1.66726975 |
| 35 | MP0005253_abnormal_eye_physiology | 1.65653336 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.64982711 |
| 37 | MP0002254_reproductive_system_inflammat | 1.61716159 |
| 38 | MP0004858_abnormal_nervous_system | 1.59458408 |
| 39 | MP0006072_abnormal_retinal_apoptosis | 1.57361698 |
| 40 | MP0002653_abnormal_ependyma_morphology | 1.57061731 |
| 41 | MP0001542_abnormal_bone_strength | 1.55507214 |
| 42 | MP0002751_abnormal_autonomic_nervous | 1.55408658 |
| 43 | MP0006082_CNS_inflammation | 1.52783876 |
| 44 | MP0002876_abnormal_thyroid_physiology | 1.52781097 |
| 45 | MP0004043_abnormal_pH_regulation | 1.51946628 |
| 46 | MP0004885_abnormal_endolymph | 1.51668971 |
| 47 | MP0005410_abnormal_fertilization | 1.46305119 |
| 48 | MP0004782_abnormal_surfactant_physiolog | 1.40609620 |
| 49 | MP0001984_abnormal_olfaction | 1.39931190 |
| 50 | MP0005379_endocrine/exocrine_gland_phen | 1.39102097 |
| 51 | MP0001270_distended_abdomen | 1.37763842 |
| 52 | MP0004145_abnormal_muscle_electrophysio | 1.34742261 |
| 53 | MP0005084_abnormal_gallbladder_morpholo | 1.34365873 |
| 54 | MP0009764_decreased_sensitivity_to | 1.29219320 |
| 55 | MP0000681_abnormal_thyroid_gland | 1.24855088 |
| 56 | MP0002067_abnormal_sensory_capabilities | 1.24714014 |
| 57 | MP0005367_renal/urinary_system_phenotyp | 1.24399690 |
| 58 | MP0000516_abnormal_urinary_system | 1.24399690 |
| 59 | MP0002064_seizures | 1.24052347 |
| 60 | MP0008775_abnormal_heart_ventricle | 1.22632583 |
| 61 | MP0003122_maternal_imprinting | 1.22487873 |
| 62 | MP0000631_abnormal_neuroendocrine_gland | 1.22139825 |
| 63 | MP0000566_synostosis | 1.18200615 |
| 64 | MP0004484_altered_response_of | 1.17918312 |
| 65 | MP0000427_abnormal_hair_cycle | 1.13753865 |
| 66 | MP0003879_abnormal_hair_cell | 1.12321772 |
| 67 | MP0004147_increased_porphyrin_level | 1.11566968 |
| 68 | MP0001346_abnormal_lacrimal_gland | 1.11141493 |
| 69 | MP0001905_abnormal_dopamine_level | 1.11100500 |
| 70 | MP0002009_preneoplasia | 1.09079990 |
| 71 | MP0002184_abnormal_innervation | 1.08898828 |
| 72 | MP0002928_abnormal_bile_duct | 1.08249039 |
| 73 | MP0000678_abnormal_parathyroid_gland | 1.08074567 |
| 74 | MP0003787_abnormal_imprinting | 1.06524542 |
| 75 | MP0005310_abnormal_salivary_gland | 1.05867564 |
| 76 | MP0000749_muscle_degeneration | 1.05023248 |
| 77 | MP0004133_heterotaxia | 1.04890840 |
| 78 | MP0005409_darkened_coat_color | 1.03603836 |
| 79 | MP0008875_abnormal_xenobiotic_pharmacok | 1.02846400 |
| 80 | MP0003941_abnormal_skin_development | 1.02055394 |
| 81 | MP0003724_increased_susceptibility_to | 1.01260470 |
| 82 | MP0003045_fibrosis | 1.01072189 |
| 83 | MP0002160_abnormal_reproductive_system | 1.00735096 |
| 84 | MP0005195_abnormal_posterior_eye | 1.00636753 |
| 85 | MP0002938_white_spotting | 1.00405264 |
| 86 | MP0002132_abnormal_respiratory_system | 0.99346033 |
| 87 | MP0005174_abnormal_tail_pigmentation | 0.95295438 |
| 88 | MP0002272_abnormal_nervous_system | 0.95138762 |
| 89 | MP0002148_abnormal_hypersensitivity_rea | 0.95074771 |
| 90 | MP0001502_abnormal_circadian_rhythm | 0.93751673 |
| 91 | MP0003635_abnormal_synaptic_transmissio | 0.93610379 |
| 92 | MP0004510_myositis | 0.92726148 |
| 93 | MP0008260_abnormal_autophagy | 0.92130302 |
| 94 | MP0004742_abnormal_vestibular_system | 0.92000933 |
| 95 | MP0002229_neurodegeneration | 0.91071834 |
| 96 | MP0005448_abnormal_energy_balance | 0.90804028 |
| 97 | MP0001440_abnormal_grooming_behavior | 0.90403964 |
| 98 | MP0005670_abnormal_white_adipose | 0.90300238 |
| 99 | MP0004085_abnormal_heartbeat | 0.88007237 |
| 100 | MP0001873_stomach_inflammation | 0.87858259 |
| 101 | MP0008995_early_reproductive_senescence | 0.87402740 |
| 102 | MP0005257_abnormal_intraocular_pressure | 0.87142713 |
| 103 | MP0005647_abnormal_sex_gland | 0.86892733 |
| 104 | MP0004130_abnormal_muscle_cell | 0.86263181 |
| 105 | MP0002572_abnormal_emotion/affect_behav | 0.85362166 |
| 106 | MP0002638_abnormal_pupillary_reflex | 0.85288390 |
| 107 | MP0000538_abnormal_urinary_bladder | 0.83946182 |
| 108 | MP0000685_abnormal_immune_system | 0.83070686 |
| 109 | MP0002063_abnormal_learning/memory/cond | 0.82989295 |
| 110 | MP0002752_abnormal_somatic_nervous | 0.81929891 |
| 111 | MP0001800_abnormal_humoral_immune | 0.80834739 |
| 112 | MP0003638_abnormal_response/metabolism_ | 0.80077356 |
| 113 | MP0003183_abnormal_peptide_metabolism | 0.80005283 |
| 114 | MP0009745_abnormal_behavioral_response | 0.78843500 |
| 115 | MP0004924_abnormal_behavior | 0.78776828 |
| 116 | MP0005386_behavior/neurological_phenoty | 0.78776828 |
| 117 | MP0001963_abnormal_hearing_physiology | 0.78549218 |
| 118 | MP0003698_abnormal_male_reproductive | 0.77812240 |
| 119 | MP0003878_abnormal_ear_physiology | 0.77731118 |
| 120 | MP0005377_hearing/vestibular/ear_phenot | 0.77731118 |
| 121 | MP0002972_abnormal_cardiac_muscle | 0.77021282 |
| 122 | MP0001664_abnormal_digestion | 0.76650467 |
| 123 | MP0003950_abnormal_plasma_membrane | 0.76208163 |
| 124 | MP0002127_abnormal_cardiovascular_syste | 0.75718063 |
| 125 | MP0005389_reproductive_system_phenotype | 0.75683169 |
| 126 | MP0002557_abnormal_social/conspecific_i | 0.75640284 |
| 127 | MP0009785_altered_susceptibility_to | 0.75634400 |
| 128 | MP0005387_immune_system_phenotype | 0.75601956 |
| 129 | MP0001790_abnormal_immune_system | 0.75601956 |
| 130 | MP0000026_abnormal_inner_ear | 0.74690929 |
| 131 | MP0003828_pulmonary_edema | 0.72124612 |
| 132 | MP0009780_abnormal_chondrocyte_physiolo | 0.71015303 |
| 133 | MP0002998_abnormal_bone_remodeling | 0.70967305 |
| 134 | MP0004036_abnormal_muscle_relaxation | 0.69972931 |
| 135 | MP0000049_abnormal_middle_ear | 0.69278717 |
| 136 | MP0004084_abnormal_cardiac_muscle | 0.66488117 |
| 137 | MP0005671_abnormal_response_to | 0.64949201 |
| 138 | MP0009046_muscle_twitch | 0.64437124 |
| 139 | MP0001919_abnormal_reproductive_system | 0.63572138 |
| 140 | MP0002693_abnormal_pancreas_physiology | 0.63270954 |
| 141 | * MP0000230_abnormal_systemic_arterial | 0.58846899 |
| 142 | MP0005165_increased_susceptibility_to | 0.56425537 |
| 143 | MP0002396_abnormal_hematopoietic_system | 0.54023337 |
| 144 | MP0004215_abnormal_myocardial_fiber | 0.53765822 |
| 145 | MP0002102_abnormal_ear_morphology | 0.51720716 |
| 146 | MP0004134_abnormal_chest_morphology | 0.51642737 |
| 147 | MP0002249_abnormal_larynx_morphology | 0.51598363 |
| 148 | MP0008058_abnormal_DNA_repair | 0.50288558 |
| 149 | MP0001486_abnormal_startle_reflex | 0.49283997 |
| 150 | MP0001186_pigmentation_phenotype | 0.48530013 |
| 151 | MP0004142_abnormal_muscle_tone | 0.48015846 |
| 152 | MP0002095_abnormal_skin_pigmentation | 0.47895576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypothermia (HP:0002045) | 4.16553932 |
| 2 | Genetic anticipation (HP:0003743) | 4.00257437 |
| 3 | Congenital stationary night blindness (HP:0007642) | 3.98451628 |
| 4 | Molar tooth sign on MRI (HP:0002419) | 3.92118080 |
| 5 | Abnormality of midbrain morphology (HP:0002418) | 3.92118080 |
| 6 | Abolished electroretinogram (ERG) (HP:0000550) | 3.73355216 |
| 7 | Abnormal hair whorl (HP:0010721) | 3.71462880 |
| 8 | Febrile seizures (HP:0002373) | 3.67542194 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 3.51572161 |
| 10 | Attenuation of retinal blood vessels (HP:0007843) | 3.43350486 |
| 11 | Abnormal ciliary motility (HP:0012262) | 3.42441409 |
| 12 | True hermaphroditism (HP:0010459) | 3.42076416 |
| 13 | Gaze-evoked nystagmus (HP:0000640) | 3.27798431 |
| 14 | Arthropathy (HP:0003040) | 3.25225376 |
| 15 | Pancreatic fibrosis (HP:0100732) | 3.21652940 |
| 16 | Hyperventilation (HP:0002883) | 3.19047139 |
| 17 | Recurrent corneal erosions (HP:0000495) | 3.12833060 |
| 18 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.12674374 |
| 19 | Tubulointerstitial nephritis (HP:0001970) | 3.06992277 |
| 20 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.06481951 |
| 21 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.06481951 |
| 22 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.05533221 |
| 23 | Pendular nystagmus (HP:0012043) | 3.03155614 |
| 24 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.01641805 |
| 25 | Type II lissencephaly (HP:0007260) | 3.00625200 |
| 26 | Distal lower limb muscle weakness (HP:0009053) | 2.93143000 |
| 27 | Increased corneal curvature (HP:0100692) | 2.82772546 |
| 28 | Keratoconus (HP:0000563) | 2.82772546 |
| 29 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.80428041 |
| 30 | Absent/shortened dynein arms (HP:0200106) | 2.80428041 |
| 31 | Medial flaring of the eyebrow (HP:0010747) | 2.78417875 |
| 32 | Prostate neoplasm (HP:0100787) | 2.77323026 |
| 33 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.76431798 |
| 34 | Patchy hypopigmentation of hair (HP:0011365) | 2.75126816 |
| 35 | Nephrogenic diabetes insipidus (HP:0009806) | 2.74878559 |
| 36 | White forelock (HP:0002211) | 2.73175965 |
| 37 | Abnormality of dental color (HP:0011073) | 2.71376048 |
| 38 | Polydipsia (HP:0001959) | 2.71156677 |
| 39 | Abnormal drinking behavior (HP:0030082) | 2.71156677 |
| 40 | Bradycardia (HP:0001662) | 2.70683913 |
| 41 | Dysautonomia (HP:0002459) | 2.67946114 |
| 42 | Submucous cleft hard palate (HP:0000176) | 2.64149377 |
| 43 | Chromsome breakage (HP:0040012) | 2.60028769 |
| 44 | Anhidrosis (HP:0000970) | 2.55986715 |
| 45 | Clumsiness (HP:0002312) | 2.52947042 |
| 46 | Renal cortical cysts (HP:0000803) | 2.50583972 |
| 47 | Large for gestational age (HP:0001520) | 2.49461119 |
| 48 | Tubular atrophy (HP:0000092) | 2.48531370 |
| 49 | Stomach cancer (HP:0012126) | 2.47144913 |
| 50 | Hypoplasia of the fovea (HP:0007750) | 2.46832704 |
| 51 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.46832704 |
| 52 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.46620847 |
| 53 | Congenital, generalized hypertrichosis (HP:0004540) | 2.46078175 |
| 54 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.45198945 |
| 55 | Decreased circulating renin level (HP:0003351) | 2.44129008 |
| 56 | Chorioretinal atrophy (HP:0000533) | 2.43454547 |
| 57 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.43046739 |
| 58 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.43007361 |
| 59 | Inability to walk (HP:0002540) | 2.42720242 |
| 60 | Sclerocornea (HP:0000647) | 2.42685029 |
| 61 | Abnormality of the right ventricle (HP:0001707) | 2.42491194 |
| 62 | Septo-optic dysplasia (HP:0100842) | 2.39396514 |
| 63 | Median cleft lip (HP:0000161) | 2.38932036 |
| 64 | Rhinitis (HP:0012384) | 2.37285952 |
| 65 | Abnormality of alanine metabolism (HP:0010916) | 2.36952552 |
| 66 | Hyperalaninemia (HP:0003348) | 2.36952552 |
| 67 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.36952552 |
| 68 | Ulnar claw (HP:0001178) | 2.35765813 |
| 69 | Congenital primary aphakia (HP:0007707) | 2.35579364 |
| 70 | Abnormality of incisor morphology (HP:0011063) | 2.34308794 |
| 71 | Absent eyebrow (HP:0002223) | 2.34067737 |
| 72 | Increased IgM level (HP:0003496) | 2.33257331 |
| 73 | Furrowed tongue (HP:0000221) | 2.32094923 |
| 74 | Cerebellar dysplasia (HP:0007033) | 2.31351029 |
| 75 | Abnormality of binocular vision (HP:0011514) | 2.28184904 |
| 76 | Diplopia (HP:0000651) | 2.28184904 |
| 77 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.28011526 |
| 78 | Gait imbalance (HP:0002141) | 2.27780445 |
| 79 | Hemiparesis (HP:0001269) | 2.27642184 |
| 80 | Atrial fibrillation (HP:0005110) | 2.26281281 |
| 81 | Congenital sensorineural hearing impairment (HP:0008527) | 2.25309025 |
| 82 | Congenital hepatic fibrosis (HP:0002612) | 2.24873940 |
| 83 | Optic nerve hypoplasia (HP:0000609) | 2.24794429 |
| 84 | Thyroid carcinoma (HP:0002890) | 2.24379509 |
| 85 | Stomatitis (HP:0010280) | 2.24217336 |
| 86 | Agitation (HP:0000713) | 2.23394486 |
| 87 | Alveolar cell carcinoma (HP:0006519) | 2.23033393 |
| 88 | Pancreatic cysts (HP:0001737) | 2.22648359 |
| 89 | Autoamputation (HP:0001218) | 2.20074415 |
| 90 | Protruding tongue (HP:0010808) | 2.18688240 |
| 91 | Methylmalonic acidemia (HP:0002912) | 2.15650231 |
| 92 | Abnormality of macular pigmentation (HP:0008002) | 2.14373239 |
| 93 | Osteomalacia (HP:0002749) | 2.13796881 |
| 94 | Anencephaly (HP:0002323) | 2.13369991 |
| 95 | Thyroid-stimulating hormone excess (HP:0002925) | 2.12707004 |
| 96 | Aplasia cutis congenita (HP:0001057) | 2.11731308 |
| 97 | Polyuria (HP:0000103) | 2.11084489 |
| 98 | Broad-based gait (HP:0002136) | 2.11048821 |
| 99 | Type I transferrin isoform profile (HP:0003642) | 2.09552008 |
| 100 | Progressive inability to walk (HP:0002505) | 2.08892718 |
| 101 | Focal motor seizures (HP:0011153) | 2.08334136 |
| 102 | Steppage gait (HP:0003376) | 2.08211602 |
| 103 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.05723965 |
| 104 | Chronic hepatic failure (HP:0100626) | 2.04816785 |
| 105 | Primary atrial arrhythmia (HP:0001692) | 2.04072122 |
| 106 | Methylmalonic aciduria (HP:0012120) | 2.03509326 |
| 107 | 3-Methylglutaconic aciduria (HP:0003535) | 2.02761608 |
| 108 | Severe visual impairment (HP:0001141) | 2.02401217 |
| 109 | Abnormality of the ischium (HP:0003174) | 2.02076440 |
| 110 | Genital tract atresia (HP:0001827) | 2.01630682 |
| 111 | Cystic liver disease (HP:0006706) | 2.00915627 |
| 112 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.00359909 |
| 113 | Abnormality of the fovea (HP:0000493) | 2.00314603 |
| 114 | Mesomelia (HP:0003027) | 2.00003814 |
| 115 | Alopecia of scalp (HP:0002293) | 1.99177110 |
| 116 | Retrobulbar optic neuritis (HP:0100654) | 1.97890912 |
| 117 | Optic neuritis (HP:0100653) | 1.97890912 |
| 118 | Duplicated collecting system (HP:0000081) | 1.97006468 |
| 119 | Abnormality of B cell number (HP:0010975) | 1.91513717 |
| 120 | Keratitis (HP:0000491) | 1.91176278 |
| 121 | Bile duct proliferation (HP:0001408) | 1.91069234 |
| 122 | Abnormal biliary tract physiology (HP:0012439) | 1.91069234 |
| 123 | Cheilitis (HP:0100825) | 1.90743430 |
| 124 | Occipital encephalocele (HP:0002085) | 1.90472658 |
| 125 | Hypoplasia of the pons (HP:0012110) | 1.89253667 |
| 126 | Epileptic encephalopathy (HP:0200134) | 1.89249042 |
| 127 | Vaginal atresia (HP:0000148) | 1.89178143 |
| 128 | Retinal dysplasia (HP:0007973) | 1.89137629 |
| 129 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.89100519 |
| 130 | Autoimmune thrombocytopenia (HP:0001973) | 1.87939667 |
| 131 | Supraventricular tachycardia (HP:0004755) | 1.87815138 |
| 132 | Barrel-shaped chest (HP:0001552) | 1.87374168 |
| 133 | Unilateral renal agenesis (HP:0000122) | 1.87257458 |
| 134 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.86596865 |
| 135 | Abnormality of the pons (HP:0007361) | 1.86546236 |
| 136 | Lissencephaly (HP:0001339) | 1.85989678 |
| 137 | Absent speech (HP:0001344) | 1.85341233 |
| 138 | Nephronophthisis (HP:0000090) | 1.85232797 |
| 139 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.84857860 |
| 140 | Asplenia (HP:0001746) | 1.84423033 |
| 141 | Postaxial foot polydactyly (HP:0001830) | 1.84149779 |
| 142 | Increased cerebral lipofuscin (HP:0011813) | 1.82983207 |
| 143 | Abnormality of the nasal septum (HP:0000419) | 1.82158380 |
| 144 | Severe muscular hypotonia (HP:0006829) | 1.81882107 |
| 145 | Decreased central vision (HP:0007663) | 1.81611238 |
| 146 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.81125007 |
| 147 | Fair hair (HP:0002286) | 1.80408751 |
| 148 | Male pseudohermaphroditism (HP:0000037) | 1.80194132 |
| 149 | Poor coordination (HP:0002370) | 1.79903226 |
| 150 | Abnormality of the renal medulla (HP:0100957) | 1.79763709 |
| 151 | Dialeptic seizures (HP:0011146) | 1.79359925 |
| 152 | Macular degeneration (HP:0000608) | 1.78193827 |
| 153 | Supraventricular arrhythmia (HP:0005115) | 1.77995876 |
| 154 | Hemiplegia (HP:0002301) | 1.77132172 |
| 155 | Abnormality of the renal collecting system (HP:0004742) | 1.76610124 |
| 156 | Thyroiditis (HP:0100646) | 1.75383154 |
| 157 | Popliteal pterygium (HP:0009756) | 1.74816430 |
| 158 | Adactyly (HP:0009776) | 1.74684274 |
| 159 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.73583596 |
| 160 | Preaxial hand polydactyly (HP:0001177) | 1.70563585 |
| 161 | Progressive sensorineural hearing impairment (HP:0000408) | 1.69782708 |
| 162 | Upper limb muscle weakness (HP:0003484) | 1.69603111 |
| 163 | Conjugated hyperbilirubinemia (HP:0002908) | 1.69427166 |
| 164 | Abnormality of the renal cortex (HP:0011035) | 1.69383588 |
| 165 | Hypomagnesemia (HP:0002917) | 1.67792023 |
| 166 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.66970989 |
| 167 | Supernumerary spleens (HP:0009799) | 1.65459586 |
| 168 | Oligohydramnios (HP:0001562) | 1.65417670 |
| 169 | Reduced antithrombin III activity (HP:0001976) | 1.65389819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.49921103 |
| 2 | SIK3 | 4.17654759 |
| 3 | ACVR1B | 3.14461742 |
| 4 | MYLK | 2.65739110 |
| 5 | ZAK | 2.59324644 |
| 6 | MATK | 2.58116365 |
| 7 | AKT3 | 2.51861932 |
| 8 | STK38L | 2.44372060 |
| 9 | ADRBK2 | 2.38607730 |
| 10 | STK24 | 2.32371205 |
| 11 | MAP4K2 | 2.26096202 |
| 12 | YES1 | 2.20635161 |
| 13 | MAP3K14 | 2.16832784 |
| 14 | PRPF4B | 2.12186533 |
| 15 | INSRR | 2.10224042 |
| 16 | SGK2 | 2.07801192 |
| 17 | NTRK1 | 2.05780622 |
| 18 | TXK | 1.96299573 |
| 19 | WNK3 | 1.93614263 |
| 20 | CDK8 | 1.90180696 |
| 21 | OBSCN | 1.71206226 |
| 22 | IRAK3 | 1.71143050 |
| 23 | MAPK15 | 1.66869917 |
| 24 | TLK1 | 1.65485849 |
| 25 | WNK4 | 1.63734420 |
| 26 | PINK1 | 1.60403388 |
| 27 | MAP3K12 | 1.53289006 |
| 28 | MAP2K7 | 1.51739532 |
| 29 | MARK3 | 1.49354827 |
| 30 | SGK494 | 1.46322482 |
| 31 | SGK223 | 1.46322482 |
| 32 | DAPK2 | 1.42557946 |
| 33 | KIT | 1.42442684 |
| 34 | BMPR1B | 1.40077394 |
| 35 | TRPM7 | 1.37365395 |
| 36 | BCR | 1.37215000 |
| 37 | TNIK | 1.31835088 |
| 38 | PIM2 | 1.30176204 |
| 39 | BMPR2 | 1.28926359 |
| 40 | FRK | 1.26975060 |
| 41 | MAPK13 | 1.26192137 |
| 42 | RIPK4 | 1.22401967 |
| 43 | OXSR1 | 1.20979154 |
| 44 | TGFBR1 | 1.19734247 |
| 45 | TEC | 1.15461463 |
| 46 | CDC42BPA | 1.12789803 |
| 47 | EPHA3 | 1.11107939 |
| 48 | NUAK1 | 1.11008410 |
| 49 | PRKCE | 1.10220907 |
| 50 | PTK2B | 1.08781939 |
| 51 | IRAK4 | 1.06936768 |
| 52 | SGK3 | 1.06821130 |
| 53 | PLK2 | 1.06176515 |
| 54 | CAMKK2 | 1.04254342 |
| 55 | MAP3K4 | 1.02244443 |
| 56 | NTRK3 | 1.01015081 |
| 57 | NLK | 1.00535520 |
| 58 | TIE1 | 0.99156192 |
| 59 | STK3 | 0.95794827 |
| 60 | ITK | 0.93525964 |
| 61 | GRK5 | 0.93450449 |
| 62 | EIF2AK2 | 0.93058612 |
| 63 | ERBB3 | 0.92111484 |
| 64 | STK39 | 0.89715697 |
| 65 | PRKCG | 0.89190095 |
| 66 | BCKDK | 0.87359700 |
| 67 | MINK1 | 0.86674249 |
| 68 | NEK6 | 0.82860935 |
| 69 | PKN1 | 0.79771880 |
| 70 | MST4 | 0.79403878 |
| 71 | SIK2 | 0.76687242 |
| 72 | NEK9 | 0.74272406 |
| 73 | SYK | 0.73897758 |
| 74 | MUSK | 0.73324466 |
| 75 | PNCK | 0.72820787 |
| 76 | RPS6KA2 | 0.72738853 |
| 77 | PAK3 | 0.72109418 |
| 78 | IRAK1 | 0.71431789 |
| 79 | BRAF | 0.69524590 |
| 80 | MAPKAPK3 | 0.67466502 |
| 81 | GRK1 | 0.65621602 |
| 82 | PIK3CG | 0.62100717 |
| 83 | BTK | 0.60878052 |
| 84 | PIK3CA | 0.60797655 |
| 85 | JAK3 | 0.60775243 |
| 86 | MAP3K6 | 0.60442517 |
| 87 | MKNK2 | 0.57952694 |
| 88 | PRKCQ | 0.56685982 |
| 89 | TAOK3 | 0.54119915 |
| 90 | CAMKK1 | 0.53826504 |
| 91 | PRKAA2 | 0.53298578 |
| 92 | IRAK2 | 0.52092790 |
| 93 | BLK | 0.51750656 |
| 94 | PRKG2 | 0.51537556 |
| 95 | ADRBK1 | 0.51527941 |
| 96 | ERBB2 | 0.51297698 |
| 97 | STK16 | 0.50759161 |
| 98 | CAMK1D | 0.50157483 |
| 99 | RPS6KC1 | 0.49709743 |
| 100 | RPS6KL1 | 0.49709743 |
| 101 | MARK1 | 0.49450895 |
| 102 | FGFR2 | 0.47798428 |
| 103 | CSF1R | 0.47425263 |
| 104 | TNK2 | 0.47376469 |
| 105 | PRKD2 | 0.46209335 |
| 106 | RPS6KA5 | 0.45803835 |
| 107 | DYRK2 | 0.45317147 |
| 108 | VRK1 | 0.44990394 |
| 109 | CSNK1A1 | 0.43541890 |
| 110 | RPS6KA6 | 0.42072829 |
| 111 | CAMK1G | 0.41680838 |
| 112 | CSNK1G2 | 0.41605611 |
| 113 | RPS6KB1 | 0.41370285 |
| 114 | FLT3 | 0.41267559 |
| 115 | MAP2K6 | 0.40989553 |
| 116 | MAPKAPK5 | 0.40928472 |
| 117 | FGFR3 | 0.40428946 |
| 118 | CDK3 | 0.40108332 |
| 119 | LCK | 0.40069272 |
| 120 | CAMK2A | 0.39789679 |
| 121 | STK11 | 0.39732927 |
| 122 | PRKCA | 0.39086567 |
| 123 | NTRK2 | 0.38703421 |
| 124 | CAMK1 | 0.38518117 |
| 125 | PRKG1 | 0.37861042 |
| 126 | IGF1R | 0.37776872 |
| 127 | ABL1 | 0.37196077 |
| 128 | MAP3K7 | 0.36675219 |
| 129 | PASK | 0.35550476 |
| 130 | FER | 0.35003690 |
| 131 | NEK2 | 0.34182831 |
| 132 | HIPK2 | 0.34032426 |
| 133 | PRKCH | 0.33577040 |
| 134 | LMTK2 | 0.32686743 |
| 135 | PRKACA | 0.32347010 |
| 136 | SGK1 | 0.31940883 |
| 137 | TAOK2 | 0.31002752 |
| 138 | GRK7 | 0.30404934 |
| 139 | PIM1 | 0.30301169 |
| 140 | MAP2K1 | 0.30026644 |
| 141 | IKBKB | 0.29008331 |
| 142 | IKBKE | 0.28654618 |
| 143 | JAK1 | 0.28440548 |
| 144 | CAMK2D | 0.27802030 |
| 145 | LYN | 0.25978287 |
| 146 | CHUK | 0.25924139 |
| 147 | MAPK3 | 0.25740935 |
| 148 | DMPK | 0.24842972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.42813658 |
| 2 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.41875044 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.12562789 |
| 4 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.05141588 |
| 5 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.97804217 |
| 6 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.97182125 |
| 7 | Taste transduction_Homo sapiens_hsa04742 | 1.96277122 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.91196790 |
| 9 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.89561695 |
| 10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.77408586 |
| 11 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.61422434 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 1.59829623 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57323931 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.54993641 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.50987639 |
| 16 | * Insulin secretion_Homo sapiens_hsa04911 | 1.49039700 |
| 17 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.47135592 |
| 18 | ABC transporters_Homo sapiens_hsa02010 | 1.47035277 |
| 19 | Nicotine addiction_Homo sapiens_hsa05033 | 1.45356868 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 1.41886506 |
| 21 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.41706944 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.39688031 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.34920596 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.34123571 |
| 25 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.32250431 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.32050841 |
| 27 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.30429644 |
| 28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.27957013 |
| 29 | Circadian rhythm_Homo sapiens_hsa04710 | 1.25108561 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.24621865 |
| 31 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.24335321 |
| 32 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.23201075 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.23191445 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.22285466 |
| 35 | Melanoma_Homo sapiens_hsa05218 | 1.21112210 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.20942945 |
| 37 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.20625161 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.18374580 |
| 39 | Phagosome_Homo sapiens_hsa04145 | 1.18069847 |
| 40 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.17509895 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.17315540 |
| 42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.16770758 |
| 43 | Circadian entrainment_Homo sapiens_hsa04713 | 1.15624903 |
| 44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.15370591 |
| 45 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.15298509 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.11274675 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.11021908 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08590740 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.08271062 |
| 50 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.06035090 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.04610718 |
| 52 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.04158323 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.03127570 |
| 54 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.02264641 |
| 55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.02259350 |
| 56 | Retinol metabolism_Homo sapiens_hsa00830 | 1.00954019 |
| 57 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.00283421 |
| 58 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.98367948 |
| 59 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.97824076 |
| 60 | RNA polymerase_Homo sapiens_hsa03020 | 0.97791337 |
| 61 | Measles_Homo sapiens_hsa05162 | 0.96739728 |
| 62 | Protein export_Homo sapiens_hsa03060 | 0.96215833 |
| 63 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.96083622 |
| 64 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.94075881 |
| 65 | Mineral absorption_Homo sapiens_hsa04978 | 0.93691682 |
| 66 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.92188338 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91845600 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89788458 |
| 69 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.89393562 |
| 70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.88893544 |
| 71 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.87241697 |
| 72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.86207094 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.84722649 |
| 74 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.83558132 |
| 75 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.83135991 |
| 76 | Basal transcription factors_Homo sapiens_hsa03022 | 0.82987461 |
| 77 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82446500 |
| 78 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.79654696 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78286865 |
| 80 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.77877772 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76708419 |
| 82 | Parkinsons disease_Homo sapiens_hsa05012 | 0.75960969 |
| 83 | Thyroid cancer_Homo sapiens_hsa05216 | 0.75084949 |
| 84 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.74948143 |
| 85 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.74110084 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70684428 |
| 87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.70496214 |
| 88 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.69387624 |
| 89 | Leishmaniasis_Homo sapiens_hsa05140 | 0.69131672 |
| 90 | Homologous recombination_Homo sapiens_hsa03440 | 0.69088449 |
| 91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.68827528 |
| 92 | Histidine metabolism_Homo sapiens_hsa00340 | 0.68800836 |
| 93 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.67973603 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66962114 |
| 95 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65504768 |
| 96 | Phototransduction_Homo sapiens_hsa04744 | 0.65242518 |
| 97 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64063571 |
| 98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.62013935 |
| 99 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60942248 |
| 100 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.60209327 |
| 101 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.60202643 |
| 102 | Salmonella infection_Homo sapiens_hsa05132 | 0.59520001 |
| 103 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.59319877 |
| 104 | GABAergic synapse_Homo sapiens_hsa04727 | 0.58959623 |
| 105 | Renin secretion_Homo sapiens_hsa04924 | 0.58827402 |
| 106 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.58342720 |
| 107 | Influenza A_Homo sapiens_hsa05164 | 0.58056985 |
| 108 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57543354 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57179287 |
| 110 | Tuberculosis_Homo sapiens_hsa05152 | 0.57022253 |
| 111 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56507925 |
| 112 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.56422661 |
| 113 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55325487 |
| 114 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.54978551 |
| 115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54927304 |
| 116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53387181 |
| 117 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.52877300 |
| 118 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52820377 |
| 119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52568586 |
| 120 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.50867689 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50446758 |
| 122 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49523784 |
| 123 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.48680125 |
| 124 | Long-term depression_Homo sapiens_hsa04730 | 0.48114429 |
| 125 | RNA degradation_Homo sapiens_hsa03018 | 0.48041214 |
| 126 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.47992226 |
| 127 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.47942776 |
| 128 | Huntingtons disease_Homo sapiens_hsa05016 | 0.47790008 |
| 129 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.47707509 |
| 130 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.47423575 |
| 131 | Platelet activation_Homo sapiens_hsa04611 | 0.47281442 |
| 132 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.46767046 |
| 133 | Melanogenesis_Homo sapiens_hsa04916 | 0.46444401 |
| 134 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45688274 |
| 135 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.45496747 |
| 136 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.45341705 |
| 137 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45117109 |
| 138 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45088874 |
| 139 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.44568998 |
| 140 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.44438940 |
| 141 | Asthma_Homo sapiens_hsa05310 | 0.43822818 |
| 142 | Salivary secretion_Homo sapiens_hsa04970 | 0.43512832 |
| 143 | Purine metabolism_Homo sapiens_hsa00230 | 0.43484673 |
| 144 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43201691 |
| 145 | Cocaine addiction_Homo sapiens_hsa05030 | 0.42992391 |
| 146 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38957190 |
| 147 | Alzheimers disease_Homo sapiens_hsa05010 | 0.38214586 |
| 148 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.33358392 |
| 149 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.32947268 |

